Overcoming the winner's curse: estimating penetrance parameters from case-control data.
暂无分享,去创建一个
[1] Johan Auwerx,et al. A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity , 1998, Nature Genetics.
[2] D Siegmund,et al. Upward bias in estimation of genetic effects. , 2002, American journal of human genetics.
[3] J. Pritchard,et al. Linkage disequilibrium in humans: models and data. , 2001, American journal of human genetics.
[4] K. Clément,et al. The Pro115Gln and Pro12Ala PPAR gamma gene mutations in obesity and type 2 diabetes , 2000, International Journal of Obesity.
[5] Eric S. Lander,et al. The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes , 2000, Nature Genetics.
[6] T. Kadowaki,et al. The Pro12Ala Polymorphism in PPAR γ2 May Confer Resistance to Type 2 Diabetes , 2000 .
[7] J. Ott,et al. Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.
[8] A. Edwards,et al. Complement Factor H Polymorphism and Age-Related Macular Degeneration , 2005, Science.
[9] Lei Sun,et al. Reduction of selection bias in genomewide studies by resampling , 2005, Genetic epidemiology.
[10] Shankuan Zhu,et al. Bias in estimates of quantitative-trait-locus effect in genome scans: demonstration of the phenomenon and a method-of-moments procedure for reducing bias. , 2002, American journal of human genetics.
[11] E. C. Capen,et al. Competitive Bidding in High-Risk Situations , 1971 .
[12] E. Lander,et al. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease , 2003, Nature Genetics.
[13] Christoph Lange,et al. Genomic screening and replication using the same data set in family-based association testing , 2005, Nature Genetics.
[14] J Blangero,et al. Large upward bias in estimation of locus-specific effects from genomewide scans. , 2001, American journal of human genetics.
[15] V. Colantuoni,et al. Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes. , 1999, Diabetes.
[16] J. Pritchard,et al. Confounding from Cryptic Relatedness in Case-Control Association Studies , 2005, PLoS genetics.
[17] J. Hirschhorn,et al. A comprehensive review of genetic association studies , 2002, Genetics in Medicine.
[18] S. Wild,et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.
[19] J. Auwerx,et al. Impact of the Peroxisome Proliferator Activated Receptor γ2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus , 2000, International Journal of Obesity.
[20] S. Engeli,et al. Pro12Ala missense mutation of the peroxisome proliferator activated receptor gamma and diabetes mellitus. , 1999, Biochemical and biophysical research communications.
[21] N Risch,et al. The Future of Genetic Studies of Complex Human Diseases , 1996, Science.
[22] F. Hu,et al. A Common Genetic Variant Is Associated with Adult and Childhood Obesity , 2006, Science.
[23] T. Kadowaki,et al. The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes. , 2000, Biochemical and biophysical research communications.